The U.S. market for cosmetic surgery, facial aesthetics and medical lasers is expected to exceed $3 billion by 2017.

In addition, new Botulinum toxin drugs are expected to enter the market, ending Allergan‘s monopoly. The market for aesthetic Botulinum toxin-A drugs such as Botox will grow to an estimated $543 million by 2017, while the aesthetic laser and light therapy markets for skin resurfacing, hair removal and laser lipolysis are the fastest growing segments.

Read more on this exciting market in iData Research’s new press release:

Cosmetic Surgery, Botox(R) and Aesthetic Laser Markets to Grow to Over $3 Billion in the U.S.